


| Key | % Net Assets |
|---|---|
| 1.1% | |
| 1.1% | |
| 1.0% | |
| 1.0% | |
| 95.8% |
| Name | % Net Assets |
|---|---|
| United Kingdom Gilt 4.25 07/06/2032 | 1.1% |
| United Kingdom Gilt 4.25 07/12/2040 | 1.1% |
| Bundesschatzanweisungen 0.25 13/12/2013 | 1.0% |
| BT Group PLC | 1.0% |
| Royal Dutch Shell PLC | 1.0% |
| AstraZeneca PLC | 0.9% |
| Unilever PLC | 0.9% |
| British American Tobacco PLC | 0.7% |
| Imperial Tobacco Group PLC | 0.7% |
| Legal & General Group PLC | 0.7% |
No asset data available.
| Date | 09-Apr-2021 |
|---|---|
| Bid | 179.90p |
| Offer | 179.90p |
| Currency | GBP |
| Change | 0.50p |
| % | 0.28% |
| YTD change | 179.90p |
| YTD % | n/a |
| Fund Inception | 26/08/1997 |
|---|---|
| Fund Manager | Sarah Arkle / Alex Lyle |
| TER | 1.46 (30-Mar-2012) |
| Minimum Investment | |
|---|---|
| Initial | £2000 |
| Additional | n/a |
| Savings | n/a |
| Charges | |
|---|---|
| Initial | 3.75% |
| Annual Mang't | 0.25% |
| Exit | n/a |
| Name | % |
|---|---|
| Standard deviation | 0.01 |
| Sharpe ratio | 0.08 |
You are here: research